Orbital Rhabdomyosarcoma: Relationship between DNA Ploidy, P53, Bcl-2, MDR-1 and Ki67 (MIB1) Expression and Clinical Behavior

Stefania Staibano, Renato Franco, Fausto Tranfa, Ernesto Mezza, Lorenzo Lo Muzio, Diego Strianese, Maria Elena Errico, Pantaileo Bufo, Gerardo Ferrara, Pasquale Somma, Gelsomina Mansueto, [No Value] Immacolatagreco, Amedeo Fiorillo, Giulio Bonavolontà, Gaetano De Rosa

Research output: Contribution to journalArticlepeer-review


Background: As for rhabdomyosarcoma (RMS) of other anatomic regions, the evaluation of traditional clinicopathological parameters does not allow the unequivocal outcome prediction of the single cases of orbital RMS. We investigated the role of DNA ploidy and immunohistochemical expression of p53, bcl-2, MDR-1 and Ki67 (MIB1) in the prognostic evaluation of orbital rhabdomyosarcomas. Materials and Methods: The study population consisted of 11 selected cases. Serial sections of each tumor, stained with Feulgen's technique, were analyzed for the DNA content, using the QUANTIMET 500c Leica analyzer, QWINVO200A software. The results were compared with the immunohistochemical expression of p53 (wild plus mutated, W&M and mutated), bcl2, MDR-1 and Ki67 (MIB1), and with follow-up data. Results: The statistical analysis of results showed that the cases of tetraploid and/or multiploid RMS, overexpressing p53 (W&M and mutated) and MDR-1, were characterized by an overall worse prognosis. On the contrary, the tumors with a favourable clinical course showed hyperexpression of MIB1 and absence of mutated p53 expression. Significantly higher MIB1 expression was found in the relapse-free group of tumors, with respect to the RMS with relapse (both in primary tumors and relative relapses, p0.05). Conclusion: The evaluation of DNA ploidy, p53, MIBI and MDR-1 expression could be used for subtyping of orbital RMS into two prognostically different subcategories, respectively RMS responder to the therapy, with favourable clinical outcome, and RMS with a worse prognosis, requiring more aggressive therapeutic protocols.

Original languageEnglish
Pages (from-to)249-257
Number of pages9
JournalAnticancer Research
Issue number1
Publication statusPublished - Jan 2004


  • bcl2
  • DNA ploidy
  • Ki67 (MIB1)
  • MDR-1
  • Orbital rhabdomyosarcoma
  • p53
  • Prognosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Orbital Rhabdomyosarcoma: Relationship between DNA Ploidy, P53, Bcl-2, MDR-1 and Ki67 (MIB1) Expression and Clinical Behavior'. Together they form a unique fingerprint.

Cite this